Detailed answers about AUGHNACLOY PHARMACY LTD, including incorporation, status, business activity, and accounts information.
When was AUGHNACLOY PHARMACY LTD founded?
AUGHNACLOY PHARMACY LTD was officially incorporated on 16 October 2003 and is registered under company number NI048293. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is AUGHNACLOY PHARMACY LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of AUGHNACLOY PHARMACY LTD?
AUGHNACLOY PHARMACY LTD's current status is Active - Proposal to Strike off. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does AUGHNACLOY PHARMACY LTD do?
AUGHNACLOY PHARMACY LTD operates in the following sector: 74990 - Non-trading company. This provides insight into the company's primary business activity and industry focus.
What is AUGHNACLOY PHARMACY LTD's registered address?
The registered office address of AUGHNACLOY PHARMACY LTD is 50 BEDFORD STREET, BELFAST, BT2 7FW. This is the official address filed with Companies House for legal and statutory correspondence.
Is AUGHNACLOY PHARMACY LTD financially stable?
The most recent accounts for AUGHNACLOY PHARMACY LTD were made up to 30 November 2020, filed as AUDITED ABRIDGED. Next accounts are due by 31 August 2022.
Does AUGHNACLOY PHARMACY LTD have any charges or mortgages?
AUGHNACLOY PHARMACY LTD has 7 registered charges, of which 3 are outstanding, 4 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.